Biomodulation and Rehabilitation Interventions to TarGet Pelvic Health

Launched by UNIVERSITY OF OTTAWA · Oct 23, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring new ways to help women who suffer from a condition called provoked vestibulodynia (PVD), which causes pain in the vulvar area during sexual activities and even at other times. The trial aims to understand how effective two treatments—photobiomodulation (a type of light therapy) and multimodal physiotherapy (a combination of different physical therapy techniques)—are at reducing this pain. Women participating in this study will be randomly assigned to one of four groups to receive either one of the treatments alone, a combination of both, or a control treatment that doesn’t have the active components.

To be eligible for the trial, participants need to be biologically born female, over 18 years old, pre-menopausal, and willing to travel to Ottawa or Quebec City. They should also be experiencing symptoms specifically related to PVD. Throughout the 14-week treatment period, participants will complete questionnaires to track their pain levels and overall satisfaction with the treatment. The study also aims to see how long the benefits last after the treatment ends. It’s a great opportunity for those who have been struggling with vulvar pain to potentially find relief and contribute to important research.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Willing to travel to Ottawa area or Quebec City area
• • Biologically born female older than eighteen years
• • Pre-menopausal
• • Not currently pregnant or pregnancy/given birth in the past six months
• • Experiencing signs and symptoms consistent with provoked vestibulodynia alone or provoked vestibulodynia plus vaginismus
• Exclusion Criteria:
• • gynaecologist cannot insert a single digit intravaginally and thus the participant would be unlikely able to tolerate the assessment procedures
• • other gynaecologic conditions such as lichen sclerosus, fissures, endometriosis, adenomyosis, or pelvic organ prolapse